Bioequivalence of Combination Products: Special Testing Challenges
Bioequivalence testing for combination products like fixed-dose pills, topical creams, and inhalers faces unique scientific and regulatory hurdles that make generic approval slower, costlier, and more uncertain than for simple drugs.
Read More